The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear¥121.04Fair value¥649.45Bull¥1,472.17
FairClose
52-week traded range
52W low ¥468.0052W high ¥1,501.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Japan Hospice Holdings Inc. closed at ¥521.00, 19.8% below the consensus fair value of ¥649.45 drawn from 9 valuation models.
Financial DNA score 42/100 — Average. P/E of 15.8x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
¥482.79
-7.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=3.7%, r=10%, tg=3%, n=10yr
Graham Number
¥570.76
+9.6%
√(22.5 × EPS × BVPS)
EPS=33.07, BVPS=437.82
P/E Fair Value
¥661.40
+26.9%
EPS × 20x (sector P/E)
EPS=33.07, Sector P/E=20x
Peter Lynch (PEG)
¥121.04
-76.8%
EPS × Growth% (PEG = 1 is fair)
EPS=33.07, g=3.7%
EV/EBITDA
¥1,472.17
+182.6%
(EBITDA × 11.8x − Net Debt) ÷ Shares
EBITDA=1.37B
Dividend Discount (DDM)
¥408.88
-21.5%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=25.01, r=10%, g=3.7%
Book Value (P/B)
¥285.89
-45.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=437.82, ROE=7.8%, g=3.7%, r=10%
Reverse DCF
¥521.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 3.9% | Historical: 3.7%
Margin of Safety
¥428.74
-17.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=571.65, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.